Wnt5a
Wnt5a (Wnt family member 5A, hWNT5A) is a secreted signalling protein of the Wnt family that acts as a ligand for frizzled receptors. It signals through both canonical and non-canonical Wnt pathways and has roles in embryonic development and cancer biology. Browse Assay Genie's current range of Wnt5a research reagents below, or read on for the biology behind the target.
Wnt5a is a ligand for members of the frizzled family of seven transmembrane receptors. Its effect on canonical Wnt signalling depends on receptor context: in the presence of FZD4 it activates beta-catenin signalling, whereas in the presence of ROR2 it inhibits the canonical pathway by promoting beta-catenin degradation through a GSK3-independent mechanism. This suppression of canonical signalling allows chondrogenesis to occur and inhibits tumour formation. Wnt5a also stimulates cell migration and inhibits type II collagen expression in chondrocytes.
The Wnt5a protein is secreted into the extracellular space and extracellular matrix. The WNT5A gene belongs to the WNT gene family, a group of structurally related genes encoding secreted signalling proteins implicated in oncogenesis and in developmental processes such as cell fate regulation and patterning during embryogenesis. NCBI describes Wnt5a as a ligand for frizzled-5 and the tyrosine kinase orphan receptor 2 (ROR2). Alternative splicing gives rise to multiple transcript variants.
During embryogenesis, Wnt5a is required for extension of the primary anterior-posterior axis and for outgrowth of the limbs and the genital tubercle. In cancer research, it is reported to decrease proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumour suppressor, while also mediating motility of melanoma cells. Mutations in the gene cause autosomal dominant Robinow syndrome. The HGNC previous name is wingless-type MMTV integration site family, member 5A.
Wnt5a is required in embryogenesis for anterior-posterior axis extension and for outgrowth of the limbs and genital tubercle.
Wnt5a can activate or inhibit canonical signalling depending on receptor context, such as FZD4 or ROR2, making it a model for pathway crosstalk.
Wnt5a stimulates cell migration, mediates melanoma cell motility and may act as a tumour suppressor in carcinoma cells.
Suppression of canonical signalling by Wnt5a allows chondrogenesis, and the protein inhibits type II collagen expression in chondrocytes.
Wnt5a is a secreted ligand for frizzled receptors and for ROR2. Depending on receptor context it can activate or inhibit canonical Wnt signalling. It stimulates cell migration, supports chondrogenesis and is required during embryonic axis extension and limb outgrowth.
The approved HGNC symbol is WNT5A, with the alias hWNT5A. The full name is Wnt family member 5A, and UniProt calls the protein Protein Wnt-5a. The earlier HGNC name was wingless-type MMTV integration site family, member 5A.
Mutations in the WNT5A gene cause autosomal dominant Robinow syndrome, and the protein may play a role in oncogenesis. Orthologues exist in mouse and rat, both named Wnt5a; check the datasheet of any product for its validated reactivity.
Other Wnt family ligands that share the secreted signalling role and pathway context of Wnt5a.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P41221; product specifications from Assay Genie datasheets.